Drugs / ex vivo expanded autologous T cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003727 | Mar 1999 → Mar 2005 | leukemia | University of Maryland, Baltimore | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ex vivo expanded autologous T cells | “Patients then receive ex vivo expanded autologous T cells on day 14 after autotransplantation.” NCT00003727 ↗ |
| Modality | Cell therapy | “ex vivo expanded autologous T cells” NCT00003727 ↗ |